# Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study

> **NCT06536556** · — · TERMINATED · sponsor: **Institut de cancérologie Strasbourg Europe** · enrollment: 5 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** First Assessment
- **OTHER:** Second Assessment

## Key facts

- **NCT ID:** NCT06536556
- **Lead sponsor:** Institut de cancérologie Strasbourg Europe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-05-02
- **Primary completion:** 2025-02-03
- **Final completion:** 2025-02-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Recruitment sufficiant in term of statistical power
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06536556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06536556, "Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06536556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*